CUAMC
RETA

China Universal Asset Management Company’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

China Universal Asset Management Company’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-433
Closed -$44.1K – 460
2023
Q2 		$44.1K Sell
433
-2
-0.5% -$204 0.01% 205
2023
Q1 		$39.6K Buy
435
+112
+35% +$10.2K 0.01% 167
2022
Q4 		$12.3K Buy
323
+28
+9% +$1.06K ﹤0.01% 209
2022
Q3 		$7K Buy
+295
New +$7K ﹤0.01% 242